These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14712707)

  • 1. Preparation and assay of RNA polymerase II elongation factors elongin and ELL.
    Kong SE; Shilatifard A; Conaway RC; Conaway JW
    Methods Enzymol; 2003; 371():276-83. PubMed ID: 14712707
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of RNA polymerase II elongation in vitro.
    Adamson TE; Shore SM; Price DH
    Methods Enzymol; 2003; 371():264-75. PubMed ID: 14712706
    [No Abstract]   [Full Text] [Related]  

  • 3. Assay of antitermination of ribosomal RNA transcription.
    Squires CL; Condon C; Seoh HK
    Methods Enzymol; 2003; 371():472-87. PubMed ID: 14712722
    [No Abstract]   [Full Text] [Related]  

  • 4. An RNA polymerase II elongation factor encoded by the human ELL gene.
    Shilatifard A; Lane WS; Jackson KW; Conaway RC; Conaway JW
    Science; 1996 Mar; 271(5257):1873-6. PubMed ID: 8596958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factors TFIIF, ELL, and Elongin negatively regulate SII-induced nascent transcript cleavage by non-arrested RNA polymerase II elongation intermediates.
    Elmendorf BJ; Shilatifard A; Yan Q; Conaway JW; Conaway RC
    J Biol Chem; 2001 Jun; 276(25):23109-14. PubMed ID: 11259417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RNA polymerase II general elongation factors.
    Reines D; Conaway JW; Conaway RC
    Trends Biochem Sci; 1996 Sep; 21(9):351-5. PubMed ID: 8870500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the intrinsic transcription termination mechanism and its control.
    Nudler E; Gusarov I
    Methods Enzymol; 2003; 371():369-82. PubMed ID: 14712715
    [No Abstract]   [Full Text] [Related]  

  • 8. Drosophila ELL is associated with actively elongating RNA polymerase II on transcriptionally active sites in vivo.
    Gerber M; Ma J; Dean K; Eissenberg JC; Shilatifard A
    EMBO J; 2001 Nov; 20(21):6104-14. PubMed ID: 11689450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assays for investigating the mechanism of promoter escape by RNA polymerase II.
    Dvir A; Conaway JW; Conaway RC
    Methods Enzymol; 2003; 370():733-40. PubMed ID: 14712687
    [No Abstract]   [Full Text] [Related]  

  • 10. ELL-associated factors 1 and 2 are positive regulators of RNA polymerase II elongation factor ELL.
    Kong SE; Banks CA; Shilatifard A; Conaway JW; Conaway RC
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10094-8. PubMed ID: 16006523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering of elongation complexes of bacterial and yeast RNA polymerases.
    Komissarova N; Kireeva ML; Becker J; Sidorenkov I; Kashlev M
    Methods Enzymol; 2003; 371():233-51. PubMed ID: 14712704
    [No Abstract]   [Full Text] [Related]  

  • 12. Using a lac repressor roadblock to analyze the E. coli transcription elongation complex.
    King RA; Sen R; Weisberg RA
    Methods Enzymol; 2003; 371():207-18. PubMed ID: 14712702
    [No Abstract]   [Full Text] [Related]  

  • 13. Assay of transient state kinetics of RNA polymerase II elongation.
    Nedialkov YA; Gong XQ; Yamaguchi Y; Handa H; Burton ZF
    Methods Enzymol; 2003; 371():252-64. PubMed ID: 14712705
    [No Abstract]   [Full Text] [Related]  

  • 14. Cloning and characterization of the EAP30 subunit of the ELL complex that confers derepression of transcription by RNA polymerase II.
    Schmidt AE; Miller T; Schmidt SL; Shiekhattar R; Shilatifard A
    J Biol Chem; 1999 Jul; 274(31):21981-5. PubMed ID: 10419521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of an RNA polymerase II elongation factor in Drosophila melanogaster.
    Gerber MA; Shilatifard A; Eissenberg JC
    Mol Cell Biol; 2005 Sep; 25(17):7803-11. PubMed ID: 16107725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical assays of Gre factors of Thermus thermophilus.
    Laptenko O; Borukhov S
    Methods Enzymol; 2003; 371():219-32. PubMed ID: 14712703
    [No Abstract]   [Full Text] [Related]  

  • 17. The FACT chromatin modulator: genetic and structure/function relationships.
    Singer RA; Johnston GC
    Biochem Cell Biol; 2004 Aug; 82(4):419-27. PubMed ID: 15284894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Techniques to analyze the HIV-1 Tat and TAR RNA-dependent recruitment and activation of the cyclin T1: CDK9 (P-TEFb) transcription elongation factor.
    Gomes N; Garber ME; Jones KA
    Methods Enzymol; 2003; 371():324-36. PubMed ID: 14712711
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of transcription-repair coupling factors in E. coli and humans.
    Selby CP; Sancar A
    Methods Enzymol; 2003; 371():300-24. PubMed ID: 14712710
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure and function of RNA polymerase II elongation factor ELL. Identification of two overlapping ELL functional domains that govern its interaction with polymerase and the ternary elongation complex.
    Shilatifard A; Haque D; Conaway RC; Conaway JW
    J Biol Chem; 1997 Aug; 272(35):22355-63. PubMed ID: 9268387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.